Anterix Inc. Cash and Equivalents

Quick Answer

Anterix Inc. reported Cash and Equivalents of $47.37 million for fiscal year 2025.

Anterix Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $47.37M -21.8%
2024 $60.58M +40.3%
2023 $43.18M -59.1%
2022 $105.62M -10.1%
2021 $117.54M -14.5%
2020 $137.45M +79.2%
2019 $76.72M -22.0%
2018 $98.32M -20.8%
2017 $124.08M -19.1%
2016 $153.46M +28.0%
2015 $119.87M +260495.7%
2014 $46.0K -76.4%
2013 $194.9K +569.1%
2012 $29.1K

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
December 31, 2025 $29.53M +2.6% -24.4%
September 30, 2025 $39.07M -9.4% -5.7%
June 30, 2025 $41.43M -19.9% -12.5%
March 31, 2025 $47.37M -21.8% +64.5%
December 31, 2024 $28.80M -53.6% -33.2%
September 30, 2024 $43.13M -11.1% -16.6%
June 30, 2024 $51.72M +78.1% -14.6%
March 31, 2024 $60.58M +40.3% -2.3%
  • Anterix Inc. showed a decrease of -21.8% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2012–2025 period, Anterix Inc.’s cash and equivalents has grown by 162501.7% (from $29.1 thousand to $47.37 million).
  • The most recent figure is from Anterix Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 24, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment